The Beijing Tong Ren Tang No. 2 Pharmaceutical Plant, located in the southeastern part of Beijing, is a large key production enterprise of the China Beijing Tong Ren Tang Holdings Corporation. Its products are well kn...The Beijing Tong Ren Tang No. 2 Pharmaceutical Plant, located in the southeastern part of Beijing, is a large key production enterprise of the China Beijing Tong Ren Tang Holdings Corporation. Its products are well known for their scientific recipes, strict processing, excellent quality and effective results. The plant, built in 1970, became a State second-class enterprise in 1989. With "quality first and credibility above everything else," the plant has developed into a key traditional Chinese medicines producer with some 1, 000 employees, an annual output value of RMB 100 million,展开更多
The Beijing Tong Ren Tang Pharmaceutical Plant, one of the oldest producers of traditional Chinese medicines in China, has a history of more than 300 years and its products are well known for their unique recipes, cho...The Beijing Tong Ren Tang Pharmaceutical Plant, one of the oldest producers of traditional Chinese medicines in China, has a history of more than 300 years and its products are well known for their unique recipes, choice ingredients, excellent technology and remarkable curative effects. Since the country began to pursue the policies of reform and opening to展开更多
Throughout the history of drug development, plants have been an important source for the discovery of novel therapeutically active compounds for many diseases. The ethnopharmacological approach has provided several le...Throughout the history of drug development, plants have been an important source for the discovery of novel therapeutically active compounds for many diseases. The ethnopharmacological approach has provided several leads to identify potential new drugs from plant sources, including those for memory disorders. For the treatment of Alzheimer's disease the drug discovery focus shifted from cholinesterase inhibitors, to other targets primarily based on two key neuropathological hallmarks, namely the hyperphosphorylation of the tau protein resulting in the formation of neurofibrillary tangles(NFTs), and the increased formation and aggregation of amyloid-beta peptide(Aβ) derived from amyloid precursor protein(APP). The present article aims to provide a comprehensive literature survey of plants and their constituents that have been tested for Aβ aggregation, thus possibly relieving several features of Alzheimer's disease(AD).展开更多
文摘The Beijing Tong Ren Tang No. 2 Pharmaceutical Plant, located in the southeastern part of Beijing, is a large key production enterprise of the China Beijing Tong Ren Tang Holdings Corporation. Its products are well known for their scientific recipes, strict processing, excellent quality and effective results. The plant, built in 1970, became a State second-class enterprise in 1989. With "quality first and credibility above everything else," the plant has developed into a key traditional Chinese medicines producer with some 1, 000 employees, an annual output value of RMB 100 million,
文摘The Beijing Tong Ren Tang Pharmaceutical Plant, one of the oldest producers of traditional Chinese medicines in China, has a history of more than 300 years and its products are well known for their unique recipes, choice ingredients, excellent technology and remarkable curative effects. Since the country began to pursue the policies of reform and opening to
基金supported by the CSIR,HRDG,Government of India,New Delhi[F.No.60(0109)/13/EMR-II]
文摘Throughout the history of drug development, plants have been an important source for the discovery of novel therapeutically active compounds for many diseases. The ethnopharmacological approach has provided several leads to identify potential new drugs from plant sources, including those for memory disorders. For the treatment of Alzheimer's disease the drug discovery focus shifted from cholinesterase inhibitors, to other targets primarily based on two key neuropathological hallmarks, namely the hyperphosphorylation of the tau protein resulting in the formation of neurofibrillary tangles(NFTs), and the increased formation and aggregation of amyloid-beta peptide(Aβ) derived from amyloid precursor protein(APP). The present article aims to provide a comprehensive literature survey of plants and their constituents that have been tested for Aβ aggregation, thus possibly relieving several features of Alzheimer's disease(AD).
